Document is current
Any future updates will be listed below
-
Authors
Ausserwinkler, Mathias https://orcid.org/0009-0000-3353-8702
Jung, Christian https://orcid.org/0000-0001-8325-250X
Paulweber, Bernhard https://orcid.org/0000-0002-1609-4676
Bauer, Johannes https://orcid.org/0009-0003-5134-4137
Kedenko, Ludmilla https://orcid.org/0009-0006-2814-0621
Kiesslich, Tobias https://orcid.org/0000-0001-5403-9478
Fixl, Barbara https://orcid.org/0009-0007-1183-6419
Trinka, Eugen https://orcid.org/0000-0002-5950-2692
Langthaler, Patrick https://orcid.org/0009-0007-7226-8371
Iglseder, Bernhard https://orcid.org/0000-0002-6132-8670
Flamm, Maria https://orcid.org/0000-0003-0816-6657
Aigner, Elmar https://orcid.org/0000-0003-0310-0536
Wernly, Bernhard https://orcid.org/0000-0003-4024-0220
-
Funding
Funding for this research was provided by:
Paracelsus Medical University
- License Information
-
More Information
Article History
Received: 15 April 2026
Accepted: 17 June 2026
First Online: 29 June 2026
Declarations
:
: E.T. has received personal honoraria for lectures and educational activities from EVER Pharma, Marinus, Arvelle, Angelini, Alexion, Argenx, Medtronic, Biocodex, Bial-Portela & Ca, NewBridge, GL Pharma, GlaxoSmithKline, Boehringer Ingelheim, LivaNova, Eisai, Epilog, UCB, Biogen, Sanofi, Jazz Pharmaceuticals and Actavis. His institution has received research grants from Biogen, UCB Pharma, Eisai, Red Bull, Merck, Bayer, the European Union, FWF Österreichischer Fonds zur Wissenschaftsförderung, the Austrian Federal Ministry for Education, Science and Research, and the Jubiläumsfonds of the Austrian National Bank. All other authors declare that they have no conflicts of interest and no competing interests.
